New version of nasal flu vaccine shows promise
Key points
- MedImmune Inc. said on Thursday that an easier-to-store version of its nasal spray flu vaccine FluMist met the main goal of a late-stage trial, which was to show that it worked as well in protecting against the flu.
- FluMist, which was approved in 2003, has had disappointing sales, in part because it needs to be kept frozen.
- MedImmune said the phase III study tested 980 people who received either CAIV-T or FluMist.
- FluMist's sales have also been restricted because it is not approved for very young children or the elderly, the most important markets for the vaccine.
MedImmune Inc. said on Thursday that an easier-to-store version of its nasal spray flu vaccine FluMist met the main goal of a late-stage trial, which was to show that it worked as well in protecting against the flu.
FluMist, which was approved in 2003, has had disappointing sales, in part because it needs to be kept frozen. The new version, called CAIV-T, only needs to be kept refrigerated. The study is a key step in the company's plan to file for regulatory approval for CAIV-T in healthy people ages 5 to 49.
MedImmune said the phase III study tested 980 people who received either CAIV-T or FluMist. Results showed equivalent antibody levels after vaccination.
FluMist's sales have also been restricted because it is not approved for very young children or the elderly, the most important markets for the vaccine. The company is working on additional studies to assess CAIV-T in children 6 months to 5 years of age.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsNew HIV therapy shows promise
Researchers may finally be on track to fight the AIDS virus by blocking a long-elusive target, an HIV enzyme called integrase. An experimental drug that inhibits the enzyme helped to keep the infection in check in…
10 July 2004
NewsWhen and Who can get a coronavirus vaccine?
Federal government officials are promising coronavirus vaccines soon - some even before Christmas - and states are gearing up to begin vaccinating Americans sometime in December. It almost sounds as if people will be…
2 December 2020
NewsAIDS treatment benefits health, economics of people without HIV, study shows
In rural Malawi, roughly 10 percent of the adult population has HIV. At the peak of the epidemic, in the 1990s and early 2000s, nearly everyone knew someone infected with or affected by the virus, what demographer…
12 December 2015